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Abstract: The breach of the skin barrier is a critical issue
associated with the treatment of individuals with transfe-
moral amputation (TFA) using osseointegrated, percutaneous
titanium implants. Thirty TFA patients scheduled for abut-
ment exchange or removal were consecutively enrolled. The
aims were to determine the macroscopic skin signs, the pres-
ence of bacteria and the gene expression in abutment-
adherent cells and to conduct correlative and comparative
analyses between the different parameters. Redness and a
granulation ring were present in 47% of the patients. Bacteria
were detected in 27/30 patients, commonly in the bone canal.
Staphylococcus aureus, coagulase-negative staphylococci,
streptococci, and Enterococcus faecalis were the most com-
mon. A positive correlation was found between TNF-a
expression and the detection of S. aureus. Staphylococcus
aureus together with other bacterial species revealed a posi-
tive relationship with MMP-8 expression. A negative correla-
tion was demonstrated between the length of the residual
femur bone and the detection of a granulation ring and
E. faecalis. A positive correlation was revealed between fix-
ture loosening and pain and the radiological detection of
endosteal bone resorption. Fixture loosening was also corre-
lated with the reduced expression of interleukin-10 and
osteocalcin. It is concluded that several relationships exist
between clinical, radiological, microbiological, and molecular
assessments of the percutaneous area of TFAs. Further long
term studies on larger patient cohorts are required to deter-
mine the precise cause-effect relationships and unravel the
role of host-bacteria interactions in the skin, bone canal and
on the abutment for the longevity of percutaneous implants
as treatment of TFA. VC 2016 The Authors Journal of Biomedical
Materials Research Part A Published by Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 105A: 578–589, 2017.
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INTRODUCTION
Clinical1–4 and experimental5 studies suggest that a percuta-
neous, osseointegrated prosthesis is an interesting and
promising alternative for the treatment of amputees. During
the past 20 years, a new method for the rehabilitation of
individuals with transfemoral amputation (TFA) has evolved.
Instead of suspension through a socket, the prosthetic leg is
directly anchored to the residual femur by an osseointe-
grated, percutaneous implant.6 The implant consists of a
titanium screw called the “fixture”, an extension called the
“abutment” and an abutment screw that keeps the two com-
ponents together. The fixture is implanted in the medullary
cavity in first-stage surgery (S1), while the abutment, which
is inserted in-second stage surgery (S2), usually 6 months
later, penetrates the skin through the skin-penetration site
(SPS). A similar concept is used for the direct anchorage of
dental implants in the jaw7 and hearing aids in the temporal
bone8 before its implementation in transfemoral and arm
amputees.9 The direct skeletal anchorage of the prosthetic
leg results in an enhanced quality of life, improved function
and fewer out-patient visits for the adjustment of the pros-
thesis compared with socket prostheses.1,10 Since roentgen
stereo photogrammetric analysis (RSA) of fixtures in TFAs
have indicated the stable fixation of the fixture in the resid-
ual bone,11 the scientific interest has converged on the SPS,
where an interface of titanium, bone, and soft tissue comes
into contact with the outer environment.
There is growing evidence that periprosthetic orthopedic
infections have a biofilm origin, are frequently subclinical
and culture negative, making the diagnosis and treatment
challenging.12
Although only a few infections leading to fixture removal
have occurred13 in arm and leg amputees and the fixture
has demonstrated a survival rate of 92% at 2 years9 in
transfemoral amputees, it can be expected that a percutane-
ous implant is at great risk and will become infected and
fail. Our knowledge of the bacteriological profile of the SPS
is still limited. Moreover, there is an absence of information
on the biological mediators, for example, pro- and anti-
inflammatory cytokines and markers of cell differentiation
and matrix remodeling,14–16 contributing to inflammation
and repair of the tissues which interface the material com-
ponents in the SPS.
The aims of this study of TFAs with bone-anchored
amputation prostheses are first, to determine the frequency
of macroscopic signs of inflammation in the SPS, to deter-
mine which bacteria are resident in the SPS, abutment and
surrounding bone canal and to analyze the gene expression
of inflammatory, bone, and soft-tissue markers in abutment-
adherent cells and, secondly, to conduct correlative and
comparative analyses between clinical signs, radiological
findings, gene expressions, and the presence of different
bacterial species.
MATERIALS AND METHODS
Implants and abutments
The materials used in this study are commercially available
components (Integrum AB, M€olndal, Sweden) [Fig. 1(A,B)].
The fixture is made of commercially pure titanium (cp-Ti),
the abutment screw of Ti6Al4V and the abutment of cp-Ti
or Ti6Al4V. The topography, oxide thickness, morphology
and crystallinity of the implants has been described else-
where.17 The surface morphology of the abutment was char-
acterized by scanning electron microscopy and interference
microscopy (Supporting Information Fig. 1).
Clinical data
Study design and patient demographics. This study was
conducted as a cross-sectional uncontrolled study. During a
2-year period, 30 consecutive TFA patients with a percuta-
neous, osseointegrated implant who had to exchange (26
patients) or remove (4 patients) their abutment were
enrolled. Patient data is found in Table I. Two of the thirty
patients were bilateral femoral amputees treated on both
sides with the implant system. In one of these patients, the
abutment on one side was exchanged. In the other patient,
both abutments were exchanged and one side was randomly
selected to be included in the study. A total of 30 abutments
in 30 patients were therefore included in the study. The rea-
son for abutment exchange was mechanical problems (26
patients) of the abutments (i.e. wear, bending, cracking, or
fracture of the abutment). One of these patients (ID 6)
received flucloxacillin (1 g x 3) due to a culture verified
superficial infection of the SPS. Three patients (ID 4, 12 and
15) were diagnosed with fixture loosening and had their
complete implant system removed. One of the three latter
patients (ID 4) had completed a course of antibiotics within
two weeks prior to implant removal due to a superficial
infection of the SPS. One patient (ID 5) had the abutment
removed and the SPS closed (leaving only the fixture in
place) because of hyperesthesia, phantom pain and pain
upon loading.
Observations and sampling at abutment exchange or
removal. The abutment exchange or removal was per-
formed in the operating theatre under sterile conditions.
The SPS and the visible part of the abutment protruding
through the skin (distal of the bone canal) were washed
with clorhexidine solution. After obtaining a swab for micro-
biology from the SPS [Fig. 1(C)], the abutment was removed
[Fig. 1(F)]. A second swab was taken from the surface of
the part of the abutment that had been located inside the
bone canal [Fig. 1(D)]. The removed abutment was then
placed in a tube containing RNAlater Stabilisation Reagent
(Qiagen, Germany) [Fig. 1(G)] for the subsequent extraction
of RNA and protein. Only the part of the abutment that was
inside the bone canal was covered by RNAlater. Next, a third
swab was obtained from the surface of the tissue in the
canal between the distal bone and the abutment, here called
bone canal [Fig. 1(E)].
The clinical appearance of the SPS was documented by
photography and macroscopically observed clinical signs
were documented by one observer. Using a modification of
the so-called Holgers scoring system18 for the assessment of
soft tissue around bone-anchored hearing aids, a modified
classification system was implemented [Fig. 1(H-K), Table
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II]. The symptoms (e.g. pain) from the stump were also
recorded. Moreover, the length of the residual femur (top of
the trochanter major to distal femur) was recorded using
radiographs. The most recent plain radiographs of the resid-
ual femur at the time of abutment exchange were examined
and compared with the postoperative (S2) plain X-ray exam-
ination. The radiographs were examined qualitatively by one
observer for signs of bone remodeling around the fixture
(Fig. 2).11 The mean time interval between the latest plain
X-ray and the time of abutment exchange was 5.8 (SD 7.4)
months. The study protocol was approved by the Regional
Ethical Review Board of Gothenburg (Dnr 110–14; 2014–
03-27). All subjects enrolled have responded to an Informed
Consent which has been approved by the Ethical Review
FIGURE 1. An overview of the implant components, the sampling procedures and the clinical assessment of the skin. (A, B) Schematic drawing
showing the implant components and surrounding tissue. Abutments with a diameter of 11 mm and a length of 72–77 mm were machined from
cp-Ti grade IV (n5 29) and titanium alloy (Ti6Al4V, grade V) (n51), cleaned by ultrasonication followed by sterilisation. (C-E) Bacterial swabs
taken from skin-penetration site (C), abutment (D) and bone canal (E). (F, G) Retrieval of abutment for macroscopic inspection (F) and placement
in a fixed volume of RNAlater (G) for subsequent RNA and protein extraction. (H-K) Representative skin-penetration sites for the scoring system:
H) Score 0: clean, dry, tight; I) Score 2: purple, serous secretion; J) Score 3: granulation ring, redness; K) Score 4: granulation ring, redness,
serous secretion.
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Board. The protocol was found acceptable and signed by
them.
Molecular analyses
RNA and protein isolation from cells adherent to the
abutment. The retrieved abutment was transported in a
vertical position and kept at 48C until further analysis. The
cells adhering to the surface of retrieved abutments in the
bone canal were homogenised by RP1 lysis buffer and rough
vortexing for three minutes. Total RNA and protein were
extracted using a NucleoSpin RNA/protein kit (Macherey-
Nagel, Germany).
Quantitative polymerase chain reaction (qPCR). Total RNA
was normalised to 20 ng/ml before transcribed to cDNA.
Primer design was performed using Primer Blast (http://
www.ncbi.nlm.nih.gov/tools/primer-blast). The sequences
are available at TATAA Biocenter AB, Gothenburg, Sweden.
The following gene panel was used: calcitonin receptor (CR),
cathepsin K (CatK), osteocalcin (OC), osteopontin (OPN) and
Runx2 (bone markers); keratin (KRT6A), collagen I (Coll1a1)
and collagen IV (Coll4a1), (soft-tissue markers); tumour
necrosis factor alpha (TNF-a), interleukin-6 (IL-6),
interleukin-10 (IL-10), interleukin-1 beta (IL-1b), matrix
metalloproteinase-8 (MMP-8), tissue inhibitor of matrix
metalloproteinase-1 (TIMP-1) and leukocyte esterase (ELA2)
(markers of inflammation, matrix-degrading enzymes and
inhibitor). Quantities of target genes were normalized using
the mean of the reference genes 18S ribosomal RNA (18S),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, zeta (YWHAZ). The normalized relative
quantities were calculated using the delta-delta Cq method
and assuming 90% PCR efficiency (k*1.9DDCq).19 The qPCR
analysis was performed with a TATAA SYBR GrandMaster Mix
(TATAA Biocenter AB) in 10 lL reactions on the CFX96 plat-
form (Bio-Rad Laboratories, CA). The qPCR procedure was
performed in accordance with the Minimum Information for
Publication of Quantitative Real-Time PCR Experiments
(MIQE) guidelines.20
Western blot. The protein concentration of the abutment
adherent cells was determined using a PierceV
R
BCA protein
assay kit (Thermo Fisher Scientific, USA). Equal amounts of
proteins (100 mg) were loaded per well separated on a 10%
Mini-ProteanV
R
TGX Precast Gel (Bio-Rad Laboratories, CA)
and transferred to nitrocellulose membranes (Bio-Rad Labo-
ratories). To prevent nonspecific binding, membranes were
blocked with 2% nonfat milk powder in 1x Tris-buffered
saline (TBS)-Tween at room temperature (RT) for 1.5 h. The
membranes were incubated at RT for 1 h with HRP-
conjugated protein A antibody (Abcam, Cambridge, UK),
diluted 1:2500 in 2% nonfat milk powder in TBS-Tween.
The membranes were washed 3 3 20 min and finally devel-
oped using an Immun-StarTMWesternCTM chemilumines-
cence detection kit (Bio-Rad Laboratories), according to the
instructions of the manufacturer. Digital detection was per-
formed using the ChemiDoc XRS1 system with Image Lab
Software (Bio-Rad Laboratories). The specificity of the anti-
body was confirmed in blot experiments using S. aureus
(ATCC 25923) (positive control) and S. epidermidis (ATCC
35984) (negative control) derived extracellular vesicles.
Bacterial cultures
Samples were taken for bacterial cultures with a sterile cot-
ton swab, transported in a coal-based medium and cultured
on general purpose and selective media according to a rou-
tine procedure at Sahlgrenska University Hospital (Clinical
Microbiology Lab, Sahlgrenska University Hospital, Gothen-
burg, Sweden). Briefly, swabs were streaked on five different
agar plates: Columbia horse blood (incubated under aerobic
and anaerobic conditions), Grand Lux (GL) plate (5% CO2),
Streptococcus plate (5% CO2), chromogenic Staphylococcus
plate and Drigalski plate, following incubation at 378C for
two to six days. A tube containing thioglycollate medium
was inoculated with each swab for enrichment, in order to
increase the detection, and incubated for six days at 378C.
All cultures were examined by experienced bacteriological
analysts and the susceptibility of the clinical isolates to sev-
eral antimicrobial agents was evaluated using the disk
TABLE I. Demographic Data on 30 Patients with TFA and
Osseointegrated Bone-Anchored Amputation Prostheses
Undergoing Exchange or Removal of Their Abutments
Variable Population
Mean
(SD)
Median
(min; max)
Patients 30
Unilateral 28
Bilateral 2
Gender (male/female) 24/6
Age at abutment
exchange (years)
51 (13) 53 (25; 76)
Time since first
surgery (S1) (years)
6.6 (3.8) 5 (0.6; 16)
Time since last exchange
of abutment (years)
4.4 (3.1) 3 (2; 13)
Estimated weight at
inclusion (S1) (kg)
77 (18) 76 (48; 116)
TABLE II. Modified Holgers Scoring System With Values
Ranging From 0 to 6 Depending on the Appearance of the
Skin-Penetration Site (SPS)
Inspection
Skin color Normal 0
Purple 1
Red 2
Moistness/secretion No 0
Serous 1
Purulent 2
Granulation No 0
Yes 1
Fistulas No 0
Yes 1
Sum 0 - 6
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diffusion method. Further identification to species level was
performed by MALDI-TOF mass spectrometry.
STATISTICS
For descriptive purposes the mean, standard deviation (SD),
median, maximum, and minimum values are presented. The
gene expression data were tested for normality, which
revealed a general non-normal distribution for all analyzed
genes. For this reason, nonparametric tests were considered
for the correlational and comparative analyses. A Spearman
correlation analysis was performed between the different
continuous and categorical (ordinal or nominal) variables.
All variables entered in the correlation analysis and the
numbers of patients (n) under each variable are described
in Supporting Information Table 1. Correlations of nominal
variables were excluded if the number of observations
within a variable was fewer than 3. Based on the correla-
tion, variables that showed significant correlations with
gene expression were further compared with respect to the
gene expression of the different biological factors analysed
in the study. Statistical analyses were performed using SPSS
software (SPSS Statistics, v.15, IBM Corporation) and p-val-
ues of <0.05 were considered significant.
RESULTS
Surface analysis
A typical machined surface morphology was revealed by
scanning electron microscopy, with scratches and ridges
along the machining direction (Supporting Information Fig.
1). A homogenous surface structure was observed along the
length of the abutment, with slightly smoother surface
structure on flat surfaces, that is the hexagon and the
TABLE III. Clinical Signs of the Skin-Penetration Site (SPS)
and Their Frequency
Clinical sign
No of
patients
(Frequency)
Percentage
(%)*
Normal skin color 7 23
Purpleness 9 30
Redness 14 47
Serous secretion 5 17
Purulent secretion 3 10
Granulation ring 14 47
Fistulas 0 0
*n5 30.
FIGURE 2. Radiological changes (A-F). (A) The early (after 3 years) postoperative X-ray from patient 1 (P1). (B) The corresponding X-ray at the
10-year post-operative follow-up of P1. Proximal trabecular buttressing (an increase of the bone density at the proximal end of the fixture) (thick,
black arrow) and cancellisation (an increase in the porosity of the cortex surrounding the fixture) (thin, black arrow) have developed. (C) The
early postoperative X-ray (after the first surgery, S1) from patient 2 (P2). (D) At two-years, a cortical thinning (a decrease in the width of the cor-
tex around the fixture) (white arrow-head) is evident. (E) An early postoperative X-ray from patient 3 (P3) after the second surgery, S2. (F). The
X-ray from patient 3 after seven years, demonstrates endosteal bone resorption (thin, white arrow) and distal bone resorption (thick, white
arrow). Endosteal bone resorption is the resorption of endosteal bone around the threads of the fixture, while distal bone resorption is the
resorption of the bone at the distal end of the fixture.
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square head. The smooth surface roughness was confirmed
by the measurements of Sa 313 nm.
Clinical symptoms and macroscopic signs
Pain upon loading was experienced by 8/30 patients,
whereas 3/30 patients experienced pain at rest. The most
common clinical sign observed in the SPS was redness and
a granulation ring, followed by purpleness and serous dis-
charge (Table III). The most frequent modified Holgers score
was 2 (on a scale of 0 to 6) with 30% (9/30) of the SPSs
having a score of 2 and 67% (20/30) a score of 2 or lower
(Table IV). Three of the 30 patients scheduled for abutment
change had symptoms and macroscopic signs indicating fix-
ture loosening and underwent removal of the entire implant
system. The detailed description of these patients is found
in Supporting Information. The clinical, radiological, and
bacteriological analyses related to these three patients are
provided in Supporting Information Table 2.
Radiology
The most common radiological change in the bone around
the fixture was proximal trabecular buttressing (14
patients), followed by endosteal bone resorption (10
patients), cancellisation (2 patients) and cortical thinning (1
patient) (Table V).
Gene expression
The sampling and extraction of RNA from cells adhering to
the abutment was successfully performed. The sampling
procedure provided good RNA quality and detectable values
for all selected genes with the exception of calcitonin
receptor.
Bacteriology
Positive bacterial cultures from routine microbiological pro-
cedures from at least one site were found in 27/30 patients.
The most commonly found bacterial species were Staphylo-
coccus aureus (14 patients; 47%), followed by streptococci
(7 patients), Enterococcus faecalis (6 patients), coagulase-
negative staphylococci (CoNS) (5 patients, including Staphy-
lococcus lugdunensis) followed by a large range of different
bacterial species (Table VI). The majority of positive bacte-
rial cultures were obtained from the bone canal (40 positive
cultures in 26 patients). Western Blot analysis of protein A
on abutments demonstrated that 28 out of 30 abutments
were positive for the protein (Figure 3). The two patients
who did not show detection of protein A presented negative
cultures, irrespective of sampling sites.
Correlation analyses
Several correlations between genes were revealed (Table
VII). A positive relationship was demonstrated between
inflammatory cytokine genes (TNF-a, IL-1b and IL-6). Fur-
thermore, all analysed inflammatory cytokines revealed a
positive correlation with TIMP-1. In addition, both inflam-
matory cytokines TNF-a and IL-6 showed positive correla-
tions with ELA2. Also, a positive relationship was found
between factors denoting tissue regeneration (Runx2 with
Coll1a1 and Coll1a1with Coll4a1). Positive correlations were
also found between factors denoting tissue regeneration and
factors denoting tissue degradation and remodeling, such as
Coll1a1 with CatK, OPN with CatK, OPN with MMP-8 and
Runx2 with ELA2. A relationship was also detected between
tissue degradation and remodelling factors (CatK and MMP-
8). On the other hand, negative correlations were shown for
the inflammatory cytokines (TNF-a and IL-1b) with tissue
regeneration genes (Coll1a1 and Coll4a1).
When correlating the clinical parameters with gene
expression activities (Table VIII), a significant negative cor-
relation was found for the loosened fixtures with the
expression levels of the bone related gene OC and the anti-
inflammatory gene IL-10. Furthermore, a negative relation-
ship was found between the time span since the S1 or
placement of the abutment with the expression of OPN,
Coll1a1, or Coll4a1.
When the correlation was performed between the differ-
ent clinical parameters (Table IX), a positive relationship
was shown between the loosened fixtures and the radiologi-
cal detection of endosteal bone resorption. Moreover, a posi-
tive association was found between the fixture loosening
and the reported pain symptom. The length of the residual
femur bone demonstrated a negative correlation with the
detection of granulation ring around the abutment.
With respect to bacterial colonisation (Table X), the anal-
ysis revealed that the detection of bacteria (irrespective of
which species) at the SPS was positively correlated to the
time span since the last abutment installation, as well as
with the detection of secretion around the abutment,
whereas the detection of bacteria in the canal was only pos-
itively correlated to the time span since S1 surgery. In addi-
tion, the detection of Enterococcus faecalis (irrespective of
TABLE IV. Modified Holgers Score
Modified Holgers score No of patients
0 4
1 7
2 9
3 5
4 3
5 2
6 0
Total 30
TABLE V. Radiological Changes
Radiological changes
since S2
No of patients
(Frequency)
Percentage
(%)*
Unchanged 10 33
Endosteal bone resorption 10 33
Distal bone resorption 0 0
Cancellisation 2 7
Cortical thinning 1 3
Proximal trabecular
buttressing
14 47
*n5 30.
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site) was positively correlated to the presence of granula-
tion tissue. A negative correlation was shown between the
length of femur bone and the detection of E. faecalis.
The correlation between bacteria and gene expression
(Table XI) revealed a positive correlation between the
expression of TNF-a and the detection of S. aureus irrespec-
tive of site. Moreover, the detection of S. aureus together
with any other bacterial species showed a positive relation-
ship with the expression of MMP-8. A detection of a polymi-
crobial flora at the different sites was positively correlated
to Runx2, IL-6 and MMP-8.
Comparative gene expression analyses
Based on the results of the correlation analysis, nominal
bacterial or clinical variables that revealed significant corre-
lations with gene expression were further evaluated by
comparative analysis. When the subjects were divided into
osseointegrated (n5 27) and loosened fixture (n5 3)
groups, the comparative gene expression analysis revealed
about a 3.5-fold lower expression of the OC in the loosened
fixture group compared with the osseointegrated one [Fig.
4(A)]. Furthermore, the loosened fixture group showed a
seven-fold lower expression of the anti-inflammatory cyto-
kine IL-10 compared with the osseointegrated group [Fig.
4(B)]. When the patients were divided based on the detec-
tion (n5 14) or absence (n5 16) of S. aureus, a two-fold
higher expression of TNF-a was registered in the group
with viable S. aureus detected [Fig. 5(A)]. This was further
verified when the patients were divided into three groups:
FIGURE 3. Western blot analysis of protein A on the abutment. Exam-
ples of positive and negative Staphylococcus aureus protein A detec-
tion on abutment. P1: One patient of two who did not demonstrate
positive detection of protein A. P2-P4: Four patients (P2-P4) with posi-
tive bands of Staphylococcus aureus protein A (50 kDa) detected in
28/30 patients.
TABLE VI. Bacterial Species Found Post Chlorhexidine Exposure at the Skin-Penetration Site (SPS), Abutment and Bone Canal
of Patients (n5 30)
Bacteria Number of patients (%) SPS Abutment Bone canal
Staphylococcus aureus 14 (47%) 7 5 13
Coagulase-negative staphylococci (CoNS) 3 (10%) 0 1 3
Staphylococcus lugdunensis 2 (7%) 0 0 2
Group B Streptococcus (GBS) 4 (13%) 1 1 4
Group G Streptococcus (GGS) 1 (3%) 0 1 1
Group A Streptococcus (GAS) 1 (3%) 1 0 1
Alpha-haemolytic streptococci 1 (3%) 0 0 1
Enterococcus faecalis 6 (20%) 0 0 6
Enterobacter spp. 1 (3%) 0 1 1
Corynebacterium simulans 1 (3%) 1 1 1
Propionibacterium acnes 1 (3%) 0 0 1
Morganella spp. 1 (3%) 0 0 1
Haemophilus parainfluenzae 1 (3%) 0 0 1
Prevotella spp. 1 (3%) 0 0 1
Anaerobic mixed flora 2 (7%) 0 0 2
Gram-positive skin flora 2 (7%) 1 1 1
No growth 3 (10%) 0 0 0
Total number of positive cultures 11*# 11*# 40*#
*Several patients displayed the growth of 2 bacterial species at the same site. #Several patients displayed the growth of bacteria in more
than one compartment.
TABLE VII. Correlation Analysis of Genes Expressed in the
Abutment-Adherent Cells
Positive correlations Negative correlations
Genes (r) (p) Genes (r) (p)
TNF-a/IL-1b 0.85 <0.01 TNF-a/OPN 20.426 <0.05
TNF-a/IL-6 0.731 <0.01 IL-1b/OPN 20.46 <0.05
TNF-a/TIMP-1 0.487 <0.01 IL-1b/Coll1a1 20.39 <0.05
TNF-a/ELA-2 0.365 <0.05 IL-1b/Coll4a1 20.378 <0.05
IL-1b/IL-6 0.721 <0.01 IL-1b/CatK 20.547 <0.01
IL-1b/TIMP-1 0.543 <0.01
IL-6/Runx2 0.452 <0.05
IL-6/TIMP-1 0.467 <0.01
IL-6/ELA2 0.446 <0.05
Coll1a1/Runx2 0.438 <0.05
Coll1a1/Coll4a1 0.777 <0.01
Coll1a1/CatK 0.501 <0.01
OPN/CatK 0.634 <0.01
OPN/MMP8 0.492 <0.01
Runx2/KRT6A 0.369 <0.05
Runx2/ELA2 0.474 <0.01
CatK/Coll4a1 0.411 <0.05
CatK/MMP8 0.622 <0.01
IL-10/ELA2 0.568 <0.01
The data show genes that revealed significant positive or nega-
tive relationships. Spearman correlation coefficients (r) and level of
significance (p) are presented.
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no detection of viable S. aureus (n5 16); single detection of
S. aureus (n5 6) and S. aureus detected with other bacteria
(n5 8) [Fig. 5(B)]. Further, a higher expression of TNF-a
was found when S. aureus was detected alone in compari-
son with no detection of S. aureus. On the other hand, a 4.5-
and 2-fold higher expression of MMP-8 was demonstrated
for S. aureus with other bacteria compared with S. aureus
detected alone and undetected, respectively [Fig. 5(C)].
DISCUSSION
The permanent penetration of the skin by a nonbiological
material represents a major clinical challenge. The breach of
the skin barrier and the presence of the material create
markedly different conditions compared with a normal
skin.21 The most common clinical signs observed in the SPS
in thirty consecutively observed patients were redness and
the presence of a granulation ring. A modification of a com-
monly used scoring system for skin status around bone-
anchored hearing aids18 did not correlate with any clinical
diagnosis, radiological, microbiological or proinflammatory
markers. The problems most frequently reported by transfe-
moral amputees are heat/sweating in the prosthetic socket
and sores/skin irritation.22 In a two-year prospective
follow-up of uni-lateral transfemoral amputees with this
percutaneous bone-anchored system, a considerable
improvement in these socket-related problems was
observed.23 Nevertheless, in comparison with percutaneous,
bone-anchored hearing aids,18 a considerably higher fre-
quency of macroscopic inflammatory signs was found in the
skin around the percutaneous, bone-anchored amputation
prostheses. Several plausible factors may explain this
difference. Firstly, there are distinct differences in anatomy
and the mechanical forces imposed on the bone and soft tis-
sue in the two regions. In amputees the implant is weight
bearing and the SPS is more mobile during ambulation and
therefore presumably more prone to inflammation. Secondly,
after amputation, the skin of the stump is considered to be
more fragile and prone to skin problems due to pre-existing
disease and surgical trauma.24
The stump skin of lower-extremity amputees wearing
artificial limbs and complying with satisfactory stump
hygiene, harbors a bacterial flora that is considerably more
abundant and polymicrobial than that of the contralateral
leg.25 In the present study, the majority of the implants
were colonised at the skin exit with various pathogenic bac-
teria, and variably but frequently along the abutment down
into the bone canal. Twenty-seven out of 30 patients had
positive cultures of potentially pathogenic bacteria such as
Staphylococcus aureus, CoNS, various groups of streptococci,
Enterococcus faecalis and Enterobacter. However, only one
patient had a clinical manifestation of infection at the SPS,
septic loosening of the fixture and a definite diagnosis of
deep infection at the time of observation. The present bacte-
rial findings are in general agreement with the results of a
prospective, bacteriological study of both leg and arm
amputees with osseointegrated prostheses.13 In the present
study, the frequency of bacteria in the SPS may be underes-
timated due to the preoperative disinfection. The vast
majority of the positive cultures in our study were derived
from the bone canal. Although bacteria were detected in
much lower frequency on the abutment compared with the
bone canal, it is of importance that protein A, a surface
TABLE VIII. Correlation Analysis Between Clinical Parametersa and Genes Expressed in the Abutment-Adherent Cells
Clinical Parameters Correlated Genes (r) (p)
Time since S1 surgery (fixture installation) OPN 20.413 <0.05
Coll4a1 20.378 <0.05
Time since last abutment installation Coll4a1 20.521 <0.01
Fixture loosening OC 20.430 <0.05
IL-10 20.404 <0.05
Length of residual femur bone OC 20.398 <0.05
aNo significant correlations were detected for other clinical parameters with any of the analyzed genes.
The data show genes that revealed significant correlations with clinical parameters. Spearman correlation coefficients (r) and level of signif-
icance (p) are presented.
TABLE IX. Correlation Analysis of Clinical Parametersa
Positive correlations Negative correlations
(r) (p) (r) (p)
Fixture loosening/Endosteal
bone resorption
0.471 <0.01 Time since S1 surgery (fixture installation)/
Fixture loosening
20.392 <0.05
Fixture loosening/Pain
symptom
0.438 <0.05 Time since S1 surgery/Pain symptom 20.412 <0.05
Skin color/Pain symptom 0.392 <0.05 Length of residual femur bone/Granulation
ring
20.479 <0.01
aNo significant correlations were detected for the other clinical parameters.
The data show clinical parameters that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level
of significance (p) are presented.
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protein in the cell wall of Staphylococcus aureus,26 was
detected on the surface of abutments from 28/30 patients.
The difference could reflect a lower sensitivity of swab sam-
pling and culturing compared with Western blot. Further,
Western blot might detect even the presence of dead staph-
ylococci that presumably existed on the abutment because
of the pre-operative scrubbing of the SPS. The findings of
viable bacteria and protein A on the abutment indicate that
the bacteria are able to adhere to the surface of the tita-
nium abutment, presumably via a surface coat of proteins
and other cell debris. Since the property of forming biofilm
constitutes an important virulence factor in bacteria, it is of
great importance to determine whether the bacteria isolated
from the abutment possess biofilm-forming abilities.
The skin has a great diversity of microorganisms that
can potentially induce infection: first, via microbial invasion
of the skin and subcutaneous tissues and, second, via the
interaction with the host defense.27 In addition, the lower
extremity has been found to be the most common location
experiencing soft tissue infections.28 Although the present
and previous observations13 suggest that the mere colonisa-
tion of the skin by bacteria is not equivalent to clinical man-
ifestation of infection, the high frequency of bacterial
colonisation indicates that the macroscopical inflammatory
signs are associated with a high bacterial burden. Support
for this assumption is that the presence of any bacteria in
the skin and the presence of E. faecalis at any of the three
sites were associated with skin secretion and a granulation
ring, respectively. Moreover, the length of the femur of the
amputated limb was positively correlated to the detection of
any bacteria on the abutment and negatively correlated to
the presence of E. faecalis. Since no significant improvements
in maintaining residual limb hygiene were achieved two
years after fitting with the osseointegrated, transcutaneous
system,23 the present findings suggest the need of enforced
and specific cleaning tools and instructions to patients. This
is supported by the frequent detection of E. faecalis in the
bone canal, and a positive Enterococcus spp. culture from one
of the loosened fixtures. Moreover, enterococcal strains, iso-
lated from implant-associated osteomyelitis in the same type
of patients, exhibited very high minimum biofilm eradication
concentrations and none of the 10 tested antimicrobials was
able to eradicate enterococcal biofilms.29 Taken together, the
present findings underscore the necessity of future studies of
the relationship between the bacterial species and the partic-
ular strain virulence, including biofilm properties and antimi-
crobial susceptibility when isolated from soft-tissue sites and
deep infections. Moreover, the search for antimicrobial strat-
egies for the prevention and control of biomaterial-associated
infections has increased during the last years. However, only
a few products are currently in clinical use, and device coat-
ing strategies are often tested and applied without taking
into consideration each unique or specific clinical applica-
tion.30 The present finding on the bacterial colonisation of
percutaneous devices strongly highlights the need for alterna-
tive antimicrobial coatings, such as contact-killing or anti-
adhesive surfaces, topical treatments, and cleaning regimens
of the SPS that can help reduce the bacterial burden and
entrance of potential pathogens into the bone site.
A variety of radiological changes in the fixture-bone
interface up to 7 years post-operatively have been described
in transfemoral11 and transhumeral9 amputees. These
changes are considered as signs of stress shielding similar
to those observed in uncemented hip stems. Our results are
TABLE X. Correlation of Bacterial and Clinical Parametersa
Bacterial findings Correlated clinical parameters (r) (p)
Detection of any bacterial species at SPS Time since last abutment installation 0.467 <0.01
Secretion 0.428 <0.05
Detection of any bacterial species on the abutment Length of residual femur bone 0.399 <0.05
Detection of any bacterial species in the bone canal Time since S1 surgery (fixture installation) 0.431 <0.05
Detection of Enterococcus faecalis irrespective of site Length of residual femur bone 20.398 <0.05
Detection of Enterococcus faecalis irrespective of site Granulation ring 0.367 <0.05
aNo significant correlations were detected for other clinical parameters with any of the analysed bacterial findings.
The data show clinical parameters that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and
level of significance (p) are presented.
TABLE XI. Correlation of Bacteria and Genesa Expressed in the Abutment-Adherent Cells
Bacterial findings Correlated genes (r) (p)
Detection of S. aureus irrespective of site TNF-a 0.394 <0.05
Detection of coagulase-negative staphylococci irrespective of site OPN 0.392 <0.05
Detection of S. aureus with other bacterial species irrespective of site MMP-8 0.531 <0.01
Detection of polymicrobial flora Runx2 0.400 <0.05
IL-6 0.423 <0.05
MMP-8 0.369 <0.05
aNo significant correlations were detected for other genes with any of the analyzed bacterial findings..
The data show genes that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of signifi-
cance (p) are presented.
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consistent with previous radiologic studies with the exception
of distal bone resorption which was not observed. The pres-
ent findings support our assumption that endosteal bone
resorption due to stress shielding or inflammation, with or
without bacterial activity, could compromise the stability of
the fixture. Although longer term studies are needed to
understand the impact of endosteal bone resorption on fix-
ture survival, this radiological finding could potentially
increase the probability of fixture loosening in years to come.
One important finding was the correlation between fix-
ture loosening and reported pain as well as radiologically
verified endosteal bone resorption. On the other hand, no
association was found between endosteal bone resorption
and bacteria in the SPS, on the abutment and in the bone
canal. At present, pain upon loading, stump swelling and
purulent secretion are regarded as important symptoms
which, together with the results of microbiological cultures
and radiologically verified osteolysis (i.e. bone resorption),
constitute the criteria for deep infections.13 However, it is
well known that amputees have a wide spectrum of pain
sensations and the perception of different types of pain, not
related to the actual transcutaneous prosthesis, does not
appear to be improved after the two-year follow-up.23
An amputee may face serious effects to the prosthesis
and the residual limb after e.g. a fall. The currently studied
amputation system has been designed to cause a bending of
the cp titanium abutment rather than fractures in the bone
and/or breakage of the fixture. However, an optimisation of
the material properties, biomechanics and antibacterial
properties is foreseen. Although the need for exchange or
removal of the abutment constituted the inclusion criterion
in the present study, the mechanical complications were not
the focus. Two-year data from a prospective study reveals a
complication rate of 8% (4/51 patients) leading to an
exchange of the abutment and/or abutment screw.1
Our study has certain limitations. The 30 selected
patients constituted a heterogeneous group with a spread in
time since fixture installation and time since the last
abutment exchange. The common feature in our cohort was
the need for abutment exchange or removal, mainly due to
the mechanical failure of the abutment. This represents a
potential selection bias, as the study could not have been
conducted on a randomly selected sample of transfemoral
amputees. The bacterial sampling was performed after dis-
infecting the SPS, which is expected to have resulted in an
under-estimation of the bacterial colonisation. Moreover,
there was a latency between X-ray and abutment exchange.
Additionally, the number of patients with loose fixture was
low which makes it difficult to draw solid conclusions in
relation to this group.
Importantly, a correlation was found between fixture loos-
ening and a lower expression of osteocalcin and IL-10. IL-10
is generally regarded as an anti-inflammatory cytokine which
is implicated in the control of the inflammatory response15
and a regulator of immunity to infection.31 IL-10 also induces
the expression of TIMPs and OPG, the respective inhibitors of
MMPs and RANKL systems,32 hence implicated in preventing
bone resorption. Myeloid-derived suppressor cell secretion of
IL-10 promotes the development of macrophage anti-
inflammatory phenotype.33 Interestingly, a monocyte and
macrophage proinflammatory gene expression and clearance
of S. aureus was demonstrated in IL-10 knock-out mice,33 at
least partly explained by inhibition of myeloid-derived sup-
pressor cells. Although a cause-effect relationship has not
been established, the present observation of S. aureus in high
frequency in the bone canal was associated with an increased
expression of TNF-a and MMP-8, suggesting a mounted
inflammatory response in order to clear the bacteria. On the
other hand, no correlation was detected between the pres-
ence of bacteria and IL-10 expression. Albeit speculative, the
multiple clinical signs of skin inflammation, an abundance of
bacteria and an increased pro-inflammatory gene expression
provide a scenario, which may ultimately lead to a degrada-
tion of the bone holding the fixture. A prerequisite is that pro-
inflammatory/degradation signals and inflammatory cells
would reach and migrate, respectively, to the actual fixture-
FIGURE 4. Gene expression of (A) osteocalcin (OC) and (B) interleukin-10 (IL-10) in the abutment-adherent cells. The comparison was performed between
patients with osseointegrated fixtures (n5 27) and patients with loosened fixtures (n5 3). Bars indicate statistically significant differences (p< 0.05).
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bone interface. Such process would be balanced by anti-
inflammatory activity and pro-regenerative activities. Inter-
estingly, this hypothesis is at least partly supported by the
finding that the three patients with fixture loosening dis-
played a lower anti-inflammatory IL-10 and pro-osteogenic
OC gene expression in abutment-adherent cells.
CONCLUDING REMARKS
 The skin penetrating abutment of amputation prostheses
was frequently colonized with pathogens and often inde-
pendent from traditional clinical signs of infection.
 While bacteria were detected in 27/30 patients, only
10% of the implants required complete removal over the
study interval.
 Collected correlations across observational, microbiologi-
cal and radiographic results indicated that the confirmed
presence of bacteria (i) increased the gene expression of
markers involved in inflammation and (ii) prompted a
potential shift of host bone homeostasis.
 Nearly half of the proximal femurs exhibited proximal
buttressing in response to the osseointegrated implant.
Endosteal bone resorption could be an alarming radio-
logical sign regarding the fixation and future survival of
the fixture especially when combined with pain at
loading.
 The current prescribed daily abutment cleaning protocol,
while considered adequate to this point to limit commen-
sal bacterial load, may require revision or improved
patient compliance.
FIGURE 5. Gene expression of tumour necrosis factor-alpha (TNF-a) and matrix metalloproteinase-8 (MMP-8) in the abutment-adherent cells. The compar-
ative analyses were performed as following: (A) TNF-a expression in patients in whom S. aureus was not detected (n516) versus patients in whom S. aur-
eus was detected (n514); (B) TNF-a expression in patients in whom S. aureus was not detected (n5 16) versus patients in whom S. aureus was detected
alone (n5 6) or detected with other bacteria (n58); (C) MMP-8 expression in patients in whom S. aureus was not detected (n5 16) versus patients in
whom S. aureus was detected alone (n5 6) or detected with other bacteria (n5 8). The bars indicate statistically significant differences (p< 0.05).
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